{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:08:36Z","timestamp":1774645716209,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.diabres.2021.109145","type":"journal-article","created":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T17:36:31Z","timestamp":1636824991000},"page":"109145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control"],"prefix":"10.1016","volume":"182","author":[{"given":"Esmeralda","family":"Castelblanco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Amig\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Real","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minerva","family":"Granado-Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inka","family":"Mi\u00f1ambres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Lecube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelino","family":"Berm\u00fadez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Julve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didac","family":"Mauricio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.diabres.2021.109145_b0005","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tem.2020.01.015","article-title":"Dyslipidemia in Type 1 Diabetes: AMaskedDanger","volume":"31","author":"Verg\u00e8s","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.diabres.2021.109145_b0010","doi-asserted-by":"crossref","first-page":"108548","DOI":"10.1016\/j.diabres.2020.108548","article-title":"Nuclear magnetic resonance-based metabolomic analysis in the assessment of preclinical atherosclerosis in type 1 diabetes and preeclampsia","volume":"171","author":"Amor","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.diabres.2021.109145_b0015","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s13300-019-0612-8","article-title":"Cardiovascular Risk in Type 1 Diabetes Mellitus","volume":"10","author":"Schofield","year":"2019","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2021.109145_b0020","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2021.109145_b0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11886-016-0700-6","article-title":"Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes","volume":"18","author":"Teleb","year":"2016","journal-title":"Curr Cardiol Rep"},{"issue":"9677","key":"10.1016\/j.diabres.2021.109145_b0030","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","article-title":"Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials","volume":"373","author":"Ray","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.diabres.2021.109145_b0035","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s00125-017-4374-4","article-title":"The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT\/EDIC study","volume":"60","author":"Bebu","year":"2017","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.diabres.2021.109145_b0040","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2337\/dci20-0022","article-title":"Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"43","author":"Chung","year":"2020","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.diabres.2021.109145_b0045","doi-asserted-by":"crossref","first-page":"e0136348","DOI":"10.1371\/journal.pone.0136348","article-title":"Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy","volume":"10","author":"Brugnara","year":"2015","journal-title":"PLoS ONE"},{"issue":"ehab293","key":"10.1016\/j.diabres.2021.109145_b0050","article-title":"Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction","author":"Varbo","year":"2021","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.diabres.2021.109145_b0055","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8","article-title":"Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes","volume":"15","author":"Laffel","year":"1999","journal-title":"Diabetes Metab Res Rev"},{"issue":"9","key":"10.1016\/j.diabres.2021.109145_b0060","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.diabres.2021.109145_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.diabres.2021.109145_b0070","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1194\/jlr.D050120","article-title":"Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy","volume":"56","author":"Mallol","year":"2015","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.diabres.2021.109145_b0075","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00216-011-5705-9","article-title":"Particle size measurement of lipoprotein fractions using diffusion-ordered NMR spectroscopy","volume":"402","author":"Mallol","year":"2012","journal-title":"Anal Bioanal Chem"},{"issue":"11","key":"10.1016\/j.diabres.2021.109145_b0080","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3390\/jcm8111875","article-title":"Specific Nuclear Magnetic Resonance Lipoprotein Subclass Profiles and Central Arterial Stiffness in Type 1 Diabetes Mellitus: A Case Control Study","volume":"8","author":"Llaurad\u00f3","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabres.2021.109145_b0085","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2337\/diacare.15.7.886","article-title":"Lipid and lipoprotein levels in patients with IDDM diabetes control and complication. Trial experience","volume":"15","year":"1992","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2021.109145_b0090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2337\/diacare.12.5.332","article-title":"Quantitative relationship between plasma lipids and glycohemoglobin in type I patients. Longitudinal study of 212 patients","volume":"12","author":"Ostlund","year":"1989","journal-title":"Diabetes Care"},{"issue":"Supplement 2","key":"10.1016\/j.diabres.2021.109145_b0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2337\/diab.41.2.S12","article-title":"Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus","volume":"41","author":"Taskinen","year":"1992","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2021.109145_b0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12933-020-01099-0","article-title":"Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles","volume":"19","author":"Amor","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.diabres.2021.109145_b0105","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.ATV.14.12.1933","article-title":"Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus","volume":"14","author":"Bagdade","year":"1994","journal-title":"Arterioscler Thromb"},{"issue":"5","key":"10.1016\/j.diabres.2021.109145_b0110","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2337\/diabetes.47.5.779","article-title":"Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects","volume":"47","author":"Malmstrom","year":"1998","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.diabres.2021.109145_b0115","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.2337\/diabetes.51.6.1949","article-title":"Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes","volume":"51","author":"Colhoun","year":"2002","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.diabres.2021.109145_b0120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11886-011-0220-3","article-title":"The role of triglycerides in atherosclerosis","volume":"13","author":"Talayero","year":"2011","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"10.1016\/j.diabres.2021.109145_b0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0021-9150(91)90006-O","article-title":"Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition","volume":"89","author":"Winocour","year":"1991","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.diabres.2021.109145_b0130","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1681\/ASN.V971277","article-title":"Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients","volume":"9","author":"Shoji","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2021.109145_b0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijcard.2018.03.128","article-title":"LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study","volume":"264","author":"Pichler","year":"2018","journal-title":"Int J Cardiol"},{"issue":"Pt 2","key":"10.1016\/j.diabres.2021.109145_b0140","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1042\/bj2850655","article-title":"Triacylglycerol accumulation and secretion in hepatocyte cultures. Effects of insulin, albumin and Triton WR 1339","volume":"285","author":"Emmison","year":"1992","journal-title":"Biochem J"},{"key":"10.1016\/j.diabres.2021.109145_b0145","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1507\/endocrj1954.37.437","article-title":"The release of hepatic triglyceride lipase from rat monolayered hepatocytes in primary culture","volume":"37","author":"Yoon","year":"1990","journal-title":"Endocrinol Jpn"},{"issue":"1","key":"10.1016\/j.diabres.2021.109145_b0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0026-0495(79)90165-3","article-title":"The effects of streptozotocin diabetes on hepatic triglyceride lipase activity in the rat","volume":"28","author":"Nakai","year":"1979","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.diabres.2021.109145_b0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2337\/diab.26.1.58","article-title":"The effects of fasting and streptozotocin diabetes on hepatic triglyceride lipase activity in the rat","volume":"26","author":"Elkeles","year":"1977","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2021.109145_b0160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2337\/diacare.17.1.6","article-title":"Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity","volume":"17","author":"Ruotolo","year":"1994","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.diabres.2021.109145_b0165","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.2337\/diabetes.51.11.3300","article-title":"Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes","volume":"51","author":"Colhoun","year":"2002","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2021.109145_b0170","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2337\/diabetes.50.3.652","article-title":"Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification","volume":"50","author":"Colhoun","year":"2001","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2021.109145_b0175","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0022-2275(20)33299-5","article-title":"Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein","volume":"39","author":"Rye","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/j.diabres.2021.109145_b0180","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2014.09.035","article-title":"Phospholipid transfer protein activity and incident type 2 diabetes mellitus","volume":"439","author":"Abbasi","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.diabres.2021.109145_b0185","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2796.2011.02465.x","article-title":"Type 2 diabetes mellitus interacts with obesity and common variations in PLTP to affect plasma phospholipid transfer protein activity","volume":"271","author":"Dullaart","year":"2012","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.diabres.2021.109145_b0190","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.atherosclerosis.2011.03.021","article-title":"Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects","volume":"217","author":"de Vries","year":"2011","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.diabres.2021.109145_b0195","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/diabetes.48.8.1631","article-title":"Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients","volume":"48","author":"Riemens","year":"1999","journal-title":"Diabetes"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721005052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721005052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:19:35Z","timestamp":1759173575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822721005052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"alternative-id":["S0168822721005052"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2021.109145","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-478979\/v1","asserted-by":"object"}]},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2021.109145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109145"}}